TET2 and cancer: A ZFP engineered with the catalytic domain (CD) of TET2, Ten-Eleven Translocation methylcytosine dioxygenase 2 (ZFP-TET2), was first reported to precisely direct demethylation and reactivation of epigenetically silenced TSGs in cervical (55) and ovarian (56) cancer cells.